Immediate Impact
4 from Science/Nature 61 standout
Citing Papers
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy
2024 Standout
Works of Martha MacLean being referenced
A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies
2008
Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Martha MacLean | 392 | 266 | 113 | 13 | 666 | |
| Valérie Méresse | 310 | 331 | 101 | 23 | 818 | |
| Kelly L. Mueller | 300 | 255 | 130 | 14 | 672 | |
| R. E. Millikan | 299 | 180 | 133 | 13 | 585 | |
| Caitlin E. Baum | 252 | 240 | 159 | 26 | 636 | |
| Annette Hayden | 379 | 237 | 85 | 17 | 712 | |
| Rosemary Chester | 383 | 362 | 266 | 11 | 846 | |
| C.J. Cornell | 231 | 174 | 119 | 19 | 837 | |
| Tsutomu Koide | 299 | 269 | 167 | 19 | 676 | |
| Sung Gil | 446 | 293 | 97 | 14 | 643 | |
| Anselmo Papa | 312 | 331 | 86 | 25 | 663 |
All Works
Loading papers...